Bayer announced that the U.S. Food and Drug Administration approved AMBELVIST (gadoquatrane), a macrocyclic gadolinium-based contrast agent for magnetic resonance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE